Effect of MaxEPA in patients with SLE. A double-blind, crossover study

Area of Science:

• Immunology
• Rheumatology
• Nutritional Science

Background:

• Systemic lupus erythematosus (SLE) is a chronic autoimmune disease.
• Omega-3 fatty acids are investigated for their anti-inflammatory properties in autoimmune conditions.

Purpose of the Study:

• To evaluate the efficacy of MaxEPA (a fish oil rich in omega-3 fatty acids) in patients with moderately active SLE.
• To compare the effects of MaxEPA against olive oil as a control in SLE patients.

Main Methods:

• A double-blind, crossover study design was employed.
• Seventeen patients with moderately active SLE were enrolled.
• Participants received either MaxEPA or olive oil for a specified period.

Main Results:

• A statistically significant improvement (p = 0.05) in clinical and serological markers was observed in 8/17 patients on MaxEPA versus 2/17 on the control after three months.
• No significant difference between MaxEPA and the control group was noted at the six-month follow-up point.

Conclusions:

• MaxEPA demonstrated a transient beneficial effect on SLE disease activity.
• The therapeutic benefits of MaxEPA for SLE appear to be short-lived, indicating limited long-term efficacy.